(Q50903271)

English

The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.

scientific article published on 15 June 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

central nervous system lymphoma

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

based on heuristic

inferred from title

author name string

San-Zhong Li

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Yong-Bo Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Wei-Dong Cao

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Yan Qu

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Peng Luo

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Hai-Ning Zhen

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Xiao-Yan Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Zhi-Feng Yan

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Zhou Fei

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

publication date

15 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

30

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

622

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Primary malignant lymphomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Solution structure of the PWWP domain of the hepatoma-derived growth factor family

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Primary central nervous system lymphoma: age and performance status are more important than treatment modality

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Treatment for primary CNS lymphoma: the next step

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0622-8

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23771798

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23771798

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23771798

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/23771798

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-013-0622-8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23771798

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50903271&oldid=2210564241"